Rhythm Biosciences launches $3.5M placement for cancer diagnostic development.
Posted on: 18/11/2024
Rhythm Biosciences to raise $3.5 million through a private placement of shares and options.
Rhythm Biosciences raises $3.5 million for ColoSTAT® colorectal cancer test development.
Healius Limited outlines strategic changes and asset sale to enhance business focus.
Posted on: 14/11/2024
Healius Limited outlines strategic sale of Lumus Imaging and leadership changes.
Rhythm Biosciences pauses trading for a major capital raising announcement.
Freedom Care Group's stock suspended pending payment talks with NDIA.
Posted on: 13/11/2024
Rhythm Biosciences updates board composition with new Managing Director and upcoming retirements.
Posted on: 29/09/2024
Rhythm Biosciences announces promising results for a new gastric cancer blood test.
Posted on: 23/09/2024
Rhythm Biosciences announces the delivery of the Alpha version of its new colorectal cancer assay kit.
Posted on: 27/08/2024